OCT 07, 2018 1:10 PM PDT

Marijuana and Anxiety

WRITTEN BY: Amy Loriaux

Like many neurotransmitters in the brain (dopamine, serotonin, etc.) where they are released in the brain is of utmost importance in determining their effects. The dose is also paramount. The old pharmacological adage "the dose determines the poison" pretty much sums up the effects of any chemical, produced in the body (endo) or taken into the body (exo), on emotions, thoughts, and behavior.

Photo creditPixabay.com

Marijuana has been recently touted as the next cure-all. In fact, Business Insider published in the spring of 2018 that smoking pot treats chronic pain, muscle spasms, may improve lung capacity, treats glaucoma, control seizures, and even fights cancer metastasis. On the mental health front, THC also is said to cause euphoric states of mind, creativity, relaxation, relieve symptoms of PTSD and anxiety (in low doses), and even decrease nightmares.

However, the one thing that seems to end up last on these lists of effects is that it can cause paranoia, psychosis, and hallucinations in large doses or in people susceptible to those diseases. Why would the same chemical have different effects? It treats anxiety and low doses but promotes paranoia at high doses. As the introductory paragraph indicates, the dose determines the poison. Furthermore, to better understand its effects is to better understand the role of endocannabinoids in the brain.

The below illustration shows all the places where endocannabinoids do their day-to-day work. THC, being an exo-canabinoid, interferes with the whole cannabinoid system. So where does it work to promote anxiety or fear? Because with all the news about marijuana's medicinal effects, this does not seem to fit the current narrative.

 

Photo credit: drugabuse.gov

A particular brain circuit that has recently been found contains regions responsible for producing a normal fear response (like if a bear is chasing you). It turns out that endocannabinoids are a part of this circuitry. In a pre-clinical study performed by Dr. Giovanni Maricano published in Neuron demonstrates that cannabinoid receptors type 1 (CB1) are needed for this fear response. Could marijuana be somehow activating these same receptors to cause certain folks to experience aversive side effects or a "bad trip"?  

In a study published in the journal Learning & Memory, Dr. Wotjak and colleagues find that THC at high doses induces fear-like behavior in mice. Furthermore, a study conducted in humans by Bagot and Chang and published in the Journal of the American Academy of Child & Adolescent Psychiatry found positive correlations between cannabis use and the onset of psychosis or bipolar disorder in the future. Again, the higher the dose used by the participants, the greater the chances of developing psychotic disorders.

This potential role of THC on the acute and long-term effects on the development of psychosis have serious clinical implications. If a clinician wants to treat a person with an anxiety disorder, then s/he has to be aware of the dose and the mental health history of his/her patient. This should also give pause in the current legalization debate. While the benefits of pot seem to be overwhelming, it is important to understand the nature and pharmacology of marijuana to prepare for adverse consequences. 

Sources: Business Insider, drugabuse.govNeuronLearning & MemoryJournal of the American Academy of Child & Adolescent Psychiatry

About the Author
  • I currently work at a small CRO involved in clinical trial management.
You May Also Like
JAN 18, 2021
Cell & Molecular Biology
MicroRNAs May be Treatment Targets for Traumatic Brain Injury
JAN 18, 2021
MicroRNAs May be Treatment Targets for Traumatic Brain Injury
Traumatic brain injury, which can happen after a blow to the head, has been called a silent epidemic and is the number o ...
FEB 24, 2021
Neuroscience
Vocal Markers for Trust and Reliability are Easily Manipulated
FEB 24, 2021
Vocal Markers for Trust and Reliability are Easily Manipulated
Why is it that some voices instinctively sound more reliable than others? Researchers have found that we identify specif ...
APR 02, 2021
Genetics & Genomics
A New Neurodevelopmental Disorder is ID'ed
APR 02, 2021
A New Neurodevelopmental Disorder is ID'ed
Researchers have identified a genetic disease that causes neurodevelopmental disorders in some affected kids. The diseas ...
APR 09, 2021
Neuroscience
Scientists Create Blood Test to Diagnose Depression and Bipolar Disorder
APR 09, 2021
Scientists Create Blood Test to Diagnose Depression and Bipolar Disorder
Up to 1 in 4 people are affected by mood disorders in their lifetimes. Due to a lack of objective diagnostic procedures, ...
APR 10, 2021
Drug Discovery & Development
How New ADHD Drug for Children Differs from Adderall
APR 10, 2021
How New ADHD Drug for Children Differs from Adderall
Over 1 in 10 children in the US aged between 5 and 17 have been diagnosed with attention deficit hyperactivity ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
Loading Comments...